Search results for: 和邦生物 矿业业务 矿权清单 官方公告
Tomocube HT-2 live cell holotomography 3D fluorescence imaging microscope
Biosan FTA-1 and FTA-2i aspirator systems
maxon motor EPOS4 24/1 motion controller for DC motors
Phenomenex Kinetex and Luna Omega columns in a 1 mm ID microbore format
Merlin MICRONAUT-S MDR/MRGN Screening 2 plate
Kaeser CSG-2 series oil-free rotary screw compressors
AdipoGen Life Sciences human netrin-1 proteins
Stem cell company prepares for Phase 1 clinical trial
Why does gestational diabetes lead to type 2 diabetes?
Merck CellASIC ONIX 2 Microfluidic Platform
$2 million for Australian maths programs
$1 million for radiopharma company
Testo Saveris 2 Wi-Fi temperature and humidity monitoring
An early step in type 1 diabetes development
Wasserlab Autwomatic Plus 1+2 water purification system
Funding a cure for type 1 diabetes
Ultrarapid insulin could revolutionise type 1 diabetes treatment
Genevax EZ-2 evaporator system for academic multi-user environments
Rising market value for type 2 diabetes mellitus treatment
Enzo Life Sciences TIMP-1 (human) ELISA kit
Enzo Life Sciences PD-1 recombinant protein
Narda Safety Test Solutions Interference and Direction Analyzer IDA 2
Euroclone S@feflow 2 Biological Safety Cabinet
GSK granted $1 million for advanced manufacturing project
Testo 635-2-HPD temperature and dewpoint meter
High-speed camera records at 1 trillion frames per second
Australian anti-PD-1 therapy to treat advanced melanoma
MSD's anti-PD1 immunotherapy pembrolizumab (trade name KEYTRUDA) has been registered by the Therapeutic Goods Administration (TGA) as monotherapy for the treatment of advanced melanoma.
[ ... ]